Document:

White Mountain Titanium Corporation: Exhibit 4.2 - Filed by newsfilecorp.com

AMENDMENT OF RIGHTS AGREEMENT 

     THIS AMENDMENT OF RIGHTS
AGREEMENT (this “Amendment”), dated as of November 29, 2013, is made by
and between White Mountain Titanium Corporation, a Nevada corporation (the
“Company”), and Interwest Transfer Company, Inc., a Utah corporation, as
rights agent (the “Rights Agent”). All capitalized terms used herein and
not otherwise defined shall have the meaning ascribed to them in the Rights
Agreement (as defined below).

RECITALS 

     WHEREAS, the Company and the
Rights Agent are parties to that certain Rights Agreement, dated as of January
18, 2011 (the “Rights Agreement”);

     WHEREAS, the Board of Directors
of the Company has determined to amend the Rights Agreement and, in furtherance
thereof, the Company desires to enter into this Amendment and Termination
pursuant to which the Rights Agreement will be amended to exempt from the
definition of Acquiring Person certain shares purchased by the Qualified Exempt
Person;

     WHEREAS, pursuant to Section 27
of the Rights Agreement, for so long as the Rights are outstanding and
redeemable, the Company may, in its sole and absolute discretion, and the Rights
Agent shall if the Company so directs, supplement or amend the Rights Agreement,
and/or any term, provision or condition of the Rights Agreement, in any respect
(except for the Redemption Price) without the consent or approval of any holder
or holders of the Rights; and

     WHEREAS, the Rights are currently
outstanding and redeemable.

AMENDMENT 

     NOW, THEREFORE, in consideration
of the premises and of the mutual covenants set forth herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows: 1. Amendment to Section 1 of the
Rights Agreement. The first paragraph of the definition of “Acquiring
Person” in Section 1 of the Rights Agreement is hereby amended and restated in
its entirety to read as follows:

“Acquiring Person” shall mean any
Person that, together with all Affiliates and Associates of such Person, shall
be the Beneficial Owner of 15% or more of the shares of Common Stock of the
Company then outstanding, but shall not include (i) the Company, (ii) any
Subsidiary of the Company, (iii) any employee benefit plan of the Company or any
Subsidiary of the Company, or any Person holding shares of Common Stock for or
pursuant to the terms of any such employee benefit plan to the extent, and only
to the extent, of such shares of Common Stock so held. Notwithstanding the
foregoing, Kin Wong together with his Affiliates and Associates (a “Qualified
Exempt Person”), who as of January 18, 2011, was the Beneficial Owner of in
excess of 15% of the Company’s outstanding Common Stock shall not be deemed an
Acquiring Person; provided however, that if after the date hereof, any Qualified
Exempt Person shall become at any time the Beneficial Owner of an additional 2%
of the shares of Common Stock of the Company then outstanding in excess of the
amount such Qualified Exempt Person beneficially owned as of the date hereof,
except for and excluding the securities purchased from the Company pursuant to
the Binding Memorandum of Understanding dated December 3, 2013, then such
Qualified Exempt Person shall be deemed an Acquiring Person hereunder as to all
of their Common Stock beneficially owned. Notwithstanding anything in this
definition of Acquiring Person to the contrary. 

     2. Continuing
Effectiveness. Except as supplemented hereby, the Rights Agreement shall
continue to be, and shall remain, in full force and effect. This Amendment shall
not be deemed (i) to be a waiver of, or consent to, or a modification or
amendment of, any other term or condition of the Rights Agreement or (ii) to
prejudice any right or rights which the parties thereto may now have or may have in
the future under or in connection with the Rights Agreement or any of the
instruments or agreements referred to therein, as the same may be amended,
restated, supplemented or otherwise modified from time to time. 

     3. Counterparts. This
Amendment may be executed in any number of counterparts, each of which shall be
deemed an original and all of which shall constitute one and the same
instrument.

     IN WITNESS WHEREOF, the
parties hereto have caused this Amendment to be duly executed, effective as of
the day and year first above written.

	 		WHITE MOUNTAIN TITANIUM CORPORATION 
	 	  	  
	 	By: 	/s/
      Brian Flower 
	 	Name: 	Brian Flower 
	 	Title: 	Executive Vice-President 
	 	  	  
	 		INTERWEST TRANSFER COMPANY, INC. 
	 	  	  
	 	By: 	/s/
      Kurtis D. Hughes 
	 	Name: 	Kurtis
      D. Hughes 
	 	Title: 	Vice
      President 

2White Mountain Titanium Corporation: Exhibit 10.31 - Filed by newsfilecorp.com

BINDING MEMORANDUM OF UNDERSTANDING 

             THIS
BINDING MEMORANDUM OF UNDERSTANDING (this “MOU”) is dated as of
December 3, 2013, between White Mountain Titanium Corporation, a Nevada
corporation (the “Company”), and Grand Agriculture Investment
Limited, a company formed in Hong Kong (the “Investor”). All
monetary denominations shall be in U.S. Dollars. 

Recitals

             A.        
The Company is engaged in mining exploration activities on its Cerro Blanco
titanium project located in Chile and is seeking funding to complete the
Environmental Impact Study and Feasibility Study on the project, and to manage
the operations of the Company. 

             B.        
The Investor is willing to provide funding for the Company on the terms provided
in this MOU and to become involved in the future operations and management of
the Company. 

Agreement

             In
consideration of the mutual covenants contained in this MOU, and for other good
and valuable consideration the receipt and adequacy of which are hereby
acknowledged, the Company and the Investor agree as follows: 

1.        
DEFINITIONS. 

             In
addition to the terms defined elsewhere in this MOU, for all purposes of this
MOU, the following terms have the meanings below: 

            
“1934 Act” means the U.S. Securities Exchange Act of 1934, as amended.

             “Board
of Directors” means the board of directors of the Company duly and validly
elected or appointed and currently sitting as directors of the Company. 

            
“Bonus Warrants” has the meaning set forth in Section 2.4. 

             “Business
Day” means any day except Saturday, Sunday and any day which is a federal or
Canadian legal holiday or a day on which banking institutions in the State of
New York or the Province of British Columbia are authorized or required by law
or other governmental action to close. 

            
“Closing” means the First Closing or the Second Closing, as applicable.

            
“Closing Date” means, as applicable, the First Closing Date or the Second
Closing Date. 

            
“Commission” means the U.S. Securities and Exchange Commission. 

             “Common
Stock” means the common stock of the Company, par value $0.001 per share,
authorized pursuant to the Company’s Amended and Restated Articles of
Incorporation, as amended from time to time. 

            
“Director Designees” has the meaning set forth in Section 2.3.

             
“First Closing” means the closing of the purchase and sale of the First
Tranche Units which shall be subdivided into two closings, one-half of which
shall occur at 4:00 pm Pacific Time on December 4, 2013, and the second half of
which shall occur at 4:00 pm Pacific Time on December 13, 2013, or such earlier
times and dates as the parties may agree. 

             “First
Closing Date” means the date on which First Closing is fully completed and
all of the conditions set forth in Sections 6.1 and 6.2 hereof are satisfied, or
such other date as the parties may agree. 

            
“First Tranche” has the meaning set forth in Section 2.2(a) . 

            
“First Tranche Shares” means the shares of Common Stock included in the
First Tranche Units. 

            
“First Tranche Unit” consists of one share of Common Stock and one First
Tranche Warrant. 

             “First
Tranche Warrant” means a warrant to purchase one share of Common Stock at
$0.45 per share exercisable immediately upon issuance through December 31, 2016,
and subject to the terms and conditions of the form of Warrant attached hereto
as Exhibit A. 

             “Material
Adverse Effect” means a material and adverse effect on the results of
operations, assets, business or condition (financial or otherwise) of the
Company and its subsidiaries, taken as a whole. 

             “Non-U.S.
Person” means any person who is not a U.S. Person or is deemed not to be a
U.S. Person under Rule 902(k)(2) of the Securities Act. 

             “Person”
means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or other entity
of any kind. 

            
“Purchase Price” has the meaning set forth in Section 2.2. 

             “Representatives”
of any Person means the affiliates, control persons, officers, directors,
employees, agents, counsel, investment bankers and other representatives of such
Person 

            
“SEC Reports” has the meaning set forth in Section 3.7. 

             “Second
Closing” means the closing of the purchase and sale of the Second Tranche
Units, which shall occur the later of April 15, 2014 or within 30 days after the
date upon which the Company’s Environmental Impact Study is completed, or such
other date as the parties may agree. 

             “Second
Closing Date” means the date on which all of the conditions set forth in
Sections 6.1 and 6.2 hereof are satisfied, or such other date as the parties may
agree. 

            
“Second Tranche” has the meaning set forth in Section 2.2(b) . 

             “Second
Tranche Shares” means the shares of Common Stock included in the Second
Tranche Units. 

             
“Second Tranche Unit” consists of one share of Common Stock and 90% of
one Second Tranche Warrant. 

2 

             “Second
Tranche Warrant” means a warrant to purchase one share of Common Stock at
$0.55 per share exercisable immediately upon issuance through December 31, 2017,
and subject to the terms and conditions of the form of Warrant attached hereto
as Exhibit B. 

            
“Securities Act” means the U.S. Securities Act of 1933, as amended. 

            
“United States” means and includes the United States of America, its
territories and possessions, any State of the United States, and the District of
Columbia. 

            
“U.S. Person” means: (i) a natural person resident in the United States;
(ii) any partnership or corporation organized or incorporated under the laws of
the United States; (iii) any estate of which any executor or administrator is a
U.S. Person; (iv) any trust of which any trustee is a U.S. Person; (v) any
agency or branch of a foreign entity located in the United States; (vi) any
nondiscretionary account or similar account (other than an estate or trust) held
by a dealer or other fiduciary for the benefit or account of a U.S. Person;
(vii) any discretionary account or similar account (other than an estate or
trust) held by a dealer or other fiduciary organized, incorporated and (if an
individual) resident in the United States; and (viii) a corporation or
partnership organized under the laws of any foreign jurisdiction and formed by a
U.S. Person principally for the purpose of investing in securities not
registered under the Securities Act, unless it is organized or incorporated, and
owned, by accredited investors (as defined in Rule 501(a) under the Securities
Act) who are not natural persons, estates or trusts. 

             “Warrant
Shares” means the shares of Common Stock issuable upon exercise of the Bonus
Warrants, the First Tranche Warrants, or the Second Tranche Warrants. 

2.        
PURCHASE AND SALE TRANSACTION. 

             2.1        
Purchase and Sale. Subject to the terms and conditions set forth
in this MOU, the Company shall issue and sell the First and Second Tranche Units
to the Investor, and the Investor shall purchase the First and Second Tranche
Units from the Company. The purchase and sale shall occur in multiple
installments as follows: 

                             (a)        
Two million eight hundred fifty-seven thousand, one hundred forty-three
(2,857,143) First Tranche Units will be purchased and sold on the initial First
Closing and two million eight hundred fifty-seven thousand, one hundred
forty-three (2,857,143) First Tranche Units will be purchased and sold on the
First Closing Date; and 

                             (b)        
Twenty Million (20,000,000) Second Tranche Units will be purchased and sold on
the Second Closing Date. 

            
2.2        
Purchase Price.

                             (a)        
The purchase price per unit for the First Tranche Units shall be $0.35 per unit
for gross proceeds of $2,000,000 (the “First Tranche”), payable one-half
at the initial First Closing and the second half at the final First Closing.

                             (b)        
The purchase price per unit for the Second Tranche Units shall be $0.40 per unit
for gross proceeds of $8,000,000 (the “Second Tranche”), payable at the
Second Closing. 

                             (c)        
The First Tranche and the Second Tranche, as applicable, will be payable by bank
wire transfer to the Company’s bank account at Scotiabank in Vancouver, Canada.
The Investor acknowledges receipt of wiring instructions for such account. 

3 

             2.3        
Director Appointments; Chairman Designation. Subject to the
provisions of Section 5.2 hereof, the Board of Directors shall appoint the
Investor and two persons designated by the Investor to serve as directors of the
Company within two (2) weeks upon full completion of the First Closing (the
“Director Designees”). Upon appointment of the Director Designees, the
Board of Directors shall appoint the Investor as the Chairman of the Board of
Directors. 

             2.4        
Bonus Warrants. In connection with the completion of the Second
Closing, the Company shall grant to the Investor at no additional cost warrants
to purchase up to 6,000,000 shares of Common Stock at $0.50 per share
exercisable immediately upon issuance and through December 31, 2017 (the
“Bonus Warrants”). The Bonus Warrants shall be in form substantially
identical to the Second Tranche Warrants. 

            
2.5        
Closing.

                             (a)        
The document deliverables for the First Closing shall be made at the offices of
counsel for the Company at 1656 Reunion Avenue, Suite 250, South Jordan, Utah
84095 on or before the First Closing Date. Deliveries received prior to the
First Closing Date shall be held in trust by counsel for the Company pending
delivery at the First Closing. The bank wire transfer of the Purchase Price for
the each subdivision of the First Closing shall be made simultaneous with the
respective Closing and proof of such wire transfer in form reasonably acceptable
to the Company shall be furnished to the Company, which action shall evidence
completion of the Closing. 

                             (b)        
The document deliverables for the Second Closing shall be made at the offices of
counsel for the Company at 1656 Reunion Avenue, Suite 250, South Jordan, Utah
84095 on or before the Second Closing Date. Deliveries received prior to the
Second Closing Date shall be held in trust by counsel for the Company pending
delivery at the Second Closing. The bank wire transfer of the Purchase Price for
the Second Closing shall be made simultaneous with the Closing and proof of such
wire transfer in form reasonably acceptable to the Company shall be furnished to
the Company, which action shall evidence completion of the Closing. 

             2.6        
Closing Deliverables. (a) At each of the subdivisions of the
First Closing (excepting subsection (iii) below which shall be delivered solely
at the initial First Closing), the Company shall deliver or cause to be
delivered to the Investor the following: 

             (i)        
A certificate evidencing the First Tranche Shares purchased in the respective
subdivision of the First Closing registered in the name of the Investor, or its
syndicate members as permitted in Section 5.3 below, all free and clear of any
liens, encumbrances or interests of any other party (other than those created by
the Investor) except for restrictions on transfer imposed by applicable
securities laws;

             (ii)        
A certificate evidencing the First Tranche Warrants purchased in the respective
subdivision of the First Closing registered in the name of the Investor, or its
syndicate members as permitted in Section 5.3 below, all free and clear of any
liens, encumbrances or interests of any other party (other than those created by
the Investor) except for restrictions on transfer imposed by applicable
securities laws; 

             (iii)        
Duly certified and adopted resolutions of the Board of Directors (1) approving
of the execution, delivery and performance of this MOU and the transactions
contemplated hereby, and (2) acknowledging the receipt of the resignation of a
sitting director and current Chairman and appointing the Director Designees and
the Investor as Chairman, each resignation and appointment to be effective as provided in Section 2.3; and 

4 

             (iv)        
Such other documents as shall be reasonably requested by the Investor to effect
the transactions contemplated by this MOU. 

                             (b)        
At the Second Closing, the Company shall deliver or cause to be delivered to the
Investor the following: 

             (i)         
 A certificate evidencing the Second Tranche Shares registered in the name
of the Investor, or its syndicate members as permitted in Section 5.3 below, all
free and clear of any liens, encumbrances or interests of any other party (other
than those created by the Investor) except for restrictions on transfer imposed
by applicable securities laws; 

             (ii)         
A certificate evidencing the Second Tranche Warrants registered in the name of
the Investor, or its syndicate members as permitted in Section 5.3 below, all
free and clear of any liens, encumbrances or interests of any other party (other
than those created by the Investor) except for restrictions on transfer imposed
by applicable securities laws; 

             (iii)        
A certificate evidencing the Bonus Warrants registered in the name of the
Investor, all free and clear of any liens, encumbrances or interests of any
other party (other than those created by the Investor) except for restrictions
on transfer imposed by applicable securities laws; and 

             (iv)        
Such other documents as shall be reasonably requested by the Investor to effect
the transactions contemplated by this MOU.

                             (c)        
At the First and Second Closings, the Investor shall deliver or cause to be
delivered to the Company, the following: 

             (i)          
Evidence of the wire transfers of the funds for the Purchase Price for each of
the subdivisions of the First Tranche and for the Second Tranches, as
applicable;

             (ii)         
At the completion of the First Closing, the written acceptance of each Director
Designee acknowledging his or her willingness to serve as a director of the
Company;

             (iii)       
The Representation Forms of any syndicate purchasers of the First or Second
Tranches, as applicable; and 

             (iv)        
Such other documents as shall be reasonably requested by the Company to effect
the transactions contemplated by this MOU. 

3.        
REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company hereby makes
the following representations and warranties to the Investor: 

             3.1        
Organization and Qualification. The Company and each of its
consolidated subsidiaries is duly incorporated, validly existing and in good
standing under the laws of the state or other jurisdiction of its organization,
with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The
Company and each of its consolidated subsidiaries is duly qualified to conduct
its businesses and is in good standing as a foreign corporation or other entity
in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be
so qualified or in good standing, as the case may be, could not, individually or
in the aggregate, reasonably be expected to result in a Material Adverse Effect
and no proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing, or seeking to revoke, limit or curtail, such power and
authority or qualification. 

5 

            
3.2        
Authorization; Enforceability. The Company has the requisite
corporate power and authority to enter into and to sell the Shares as
contemplated by this MOU. The execution and delivery of this MOU by the Company
and the sale of the securities contemplated hereby have been duly authorized by
all necessary action on the part of the Company and no further action is
required by the Company in connection therewith. This MOU has been duly executed
by the Company and, when delivered in accordance with the terms hereof, will
constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally the enforcement
of, creditors’ rights and remedies or by other equitable principles of general
application. 

             3.3        
No Conflicts. The execution, delivery and performance of this
MOU by the Company and the consummation by the Company of the transactions
contemplated hereby do not and will not (i) conflict with or violate any
provision of the Company’s articles of incorporation or bylaws, or (ii) conflict
with, or constitute a default (or an event that with notice or lapse of time or
both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time
or both) of, or result in the imposition of any restriction whatsoever upon any
of the material properties or assets of the Company pursuant to, any agreement,
credit facility, debt or other instrument (evidencing a Company debt or
otherwise) or other understanding to which the Company is a party or by which
any property or asset of the Company is bound or affected, except, such as could
not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect.

             3.4        
Capitalization. The Company is authorized to issue 500,000,000
shares of its Common Stock and 100,000,000 shares of preferred stock. As of the
date of this MOU, there were outstanding (i) 68,141,107 shares of Common Stock,
(ii) no shares of preferred stock, (iii) options to purchase an aggregate of
150,000 shares of Common Stock, (iv) a maximum of 7,048,299 shares of Common
Stock that were issuable pursuant to the exercise of outstanding warrants, and
(v) a maximum of 1,725,000 shares of Common Stock that were reserved for
issuance upon completion of certain milestones by designated parties. There are
no other derivatives outstanding entitling the holder to acquire shares of
common or preferred stock of the Company nor is there any outstanding
indebtedness of the Company that is convertible into, exchangeable or
exercisable for, capital stock of the Company. All shares of common stock are
equal to each other with respect to voting, liquidation, dividend, and other
rights. Owners of shares are entitled to one vote for each share owned at any
shareholders’ meeting. Holders of shares are entitled to receive such dividends
as may be declared by the Board of Directors out of funds legally available
therefore; and upon liquidation, are entitled to participate pro rata in a
distribution of assets available for such a distribution to shareholders. The
common stock of the Company does not have cumulative voting rights.

             3.5        
Reports, Consents and Approvals. The Company is not required to
obtain any consent, waiver, authorization or order of, give any notice to, or
make any filing or registration with, any court or other federal, state, local
or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of this MOU and the
consummation of the transactions contemplated hereby, other than (i) filings
required by state securities laws, (ii) the filing of a Notice of Sale of
Securities on Form D with the Commission under Regulation D of the Securities
Act, and (iii) those that have been made or obtained prior to the date of this
MOU.

6 

             3.6        
Issuance of the Shares. The First and Second Tranche Shares and
the Warrant Shares have been duly authorized and, when paid for in accordance
with this MOU, will be duly and validly issued, fully paid and nonassessable,
free and clear of all of all liens, encumbrances, interests and restrictions
(other than those created by the Investor), except for restrictions on transfer
imposed by applicable securities laws. 

             3.7        
SEC Reports; Financial Statements. A reasonable time prior to
the date of this MOU, the Company has made available to the Investor through the
EDGAR system, true and complete copies of the Company’s most recent Annual
Report on Form 10-K for the fiscal year ended December 31, 2012 (the
“10-K”), and all other reports filed by the Company with the Commission
since the filing of the 10-K and prior to the date hereof (collectively, the
“SEC Reports”). The SEC Reports are the only filings required of the
Company pursuant to the 1934 Act for such period. The SEC Reports do not contain
any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in the light of the
circumstances under which they were made, not misleading. The financial
statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such
financial statements have been prepared in accordance with generally accepted
accounting principles in the United States (“GAAP”) applied on a
consistent basis during the periods involved, except as may be otherwise
specified in such financial statements or the notes thereto, and fairly present
in all material respects the financial position of the Company and its
consolidated subsidiaries as of and for the dates thereof and the results of
operations and cash flows for the periods then ended, subject, in the case of
unaudited statements, to normal, immaterial, year-end audit adjustments. Except
as otherwise disclosed in this MOU, there have been no material changes in the
Company’s affairs not disclosed in the SEC Reports.

             3.8        
No Material Changes. Since the date of the latest financial
statements included within the SEC Reports, except as specifically disclosed in
the SEC Reports, (i) there has been no event, occurrence or development that has
had or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables, accrued expenses and other liabilities incurred
in the ordinary course of business consistent with past practice and (B)
liabilities not required to be reflected in the Company’s financial statements
pursuant to GAAP or required to be disclosed in filings made with the
Commission, (iii) the Company has not altered its method of accounting or the
identity of its auditors, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased,
redeemed or made any MOUs to purchase or redeem any shares of its capital stock,
and (v) the Company has not issued any equity securities to any officer,
director or affiliate, except pursuant to existing Company stock option
plans.

             3.9        
Litigation. There is no Action which adversely affects or
challenges the legality, validity or enforceability of this MOU. For purposes of
this MOU, “Action” means any action, suit, inquiry, notice of violation,
proceeding (including any partial proceeding such as a deposition) or
investigation pending or, to the knowledge of the Company, threatened in writing
against the Company or any of its properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign). 

             3.10        
Use of Proceeds. The proceeds of this offering will be allocated
for the following purposes, which allocations are subject to reasonable
alternations based upon the results of operations. 

7 

                    
(a)         Proceeds from the First
Tranche. 

	 	  	 	First Tranche 	 	 	  	 
	 	Uses of the Proceeds 	 	Proceeds 	 	 	Percentage 	 
	 	Maximum Selling Commissions 	$	 140,000 	 	 	7.0% 	 
	 	Offering Costs 	 	15,000 	 	 	0.8% 	 
	 	Geophysics 	 	150,000 	 	 	7.5% 	 
	 	Hydrogeology & Drilling 	 	500,000 	 	 	25.0% 	 
	 	Dust Monitoring 	 	80,000 	 	 	4.0% 	 
	 	Pipeline Engineering 	 	150,000 	 	 	7.5% 	 
	 	Easements for Desalination Plant 	 	85,000 	 	 	4.2% 	 
	 	Independent Environmental Consultants 	 	200,000 	 	 	10.0% 	 
	 	Legal Expenses for Project 	 	180,000 	 	 	9.0% 	 
	 	General & Administrative Operating Expenses 	 	500,000 	 	 	25.0%
    	 
	 	                       
      Total 	$	2,000,000 	 	 	100% 	 

                    
(b)         Proceeds from the Second
Tranche: 

	 	  	 	Second Tranche 	 	 	  	 
	 	Uses of the Proceeds 	 	Proceeds 	 	 	Percentage 	 
	 	Maximum Selling Commissions 	$	 560,000 	 	 	7.0% 	 
	 	Offering Costs 	 	15,000 	 	 	0.2% 	 
	 	R & D 	 	340,000 	 	 	4.3% 	 
	 	Infill Drilling 	 	1,500,000 	 	 	18.7% 	 
	 	Land Acquisition and Easements 	 	700,000 	 	 	8.8% 	 
	 	Final Engineering 	 	2,300,000 	 	 	28.7% 	 
	 	Additional Working Capital and
      Contingencies 	 	2,585,000 	 	 	32.3% 	 
	 	                       
      Total 	$	8,000,000 	 	 	100% 	 

4.        
REPRESENTATIONS AND WARRANTIES OF THE INVESTOR. The Investor
hereby represents and warrants to the Company as follows: 

     4.1        
Enforceability. This MOU has been duly executed by the Investor
and, when delivered in accordance with the terms hereof, will constitute the
valid and binding obligation of the Investor enforceable against the Investor in
accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general application.

     4.2        
Restricted Securities. The Investor has been advised and
acknowledges that: (i) neither the First or Second Tranche Units, the Bonus
Warrants, nor the Warrant Shares have been, and when issued, will not be,
registered under the Securities Act, the securities laws of any state of the
United States or the securities laws of any other country or jurisdiction; (ii)
in issuing and selling the First and Second Tranche Units, Bonus Warrants and
Warrant Shares to the Investor, the Company is relying upon the “safe harbor”
provided by Regulation S and/or on Section 4(a)(2) or 4(a)(5) under the
Securities Act; (iii) it is a condition to the availability of the Regulation S
“safe harbor” that the Units not be offered or sold in the United States or to a
U.S. Person until the expiration of a period of six months following the Second
Closing Date (the “Restricted Period”); and (iv) notwithstanding the
foregoing, prior to the expiration of Restricted Period, the securities may be
offered and sold by the Investor only if such offer and sale is made in
compliance with the terms of this MOU and either: (i) if the offer or sale is
within the United States or to or for the account of a U.S. Person, the
securities are offered and sold pursuant to an effective registration statement
or pursuant to Rule 144 under the Securities Act or pursuant to an exemption
from the registration requirements of the Securities Act; or (ii) the offer and
sale is outside the United States and to other than a U.S. Person. 

8 

             4.3        
Investment Intent. The Investor is acquiring the First and
Second Tranche Units and the Bonus Warrants for its own account for investment
purposes only and not with a view to or for distributing or reselling the
securities. Subject to the provisions of Section 5.3, the Investor does not have
any agreement or understanding, directly or indirectly, with any Person to
distribute any of the First or Second Tranche Units, the Bonus Warrants, or the
Warrant Shares. 

             4.4        
Investor Status. At the time the Investor was offered the First
and Second Tranche Units and the Bonus Warrants, the Investor was, and at the
date hereof it is, an “accredited investor” as defined in Rule 501(a) under the
Securities Act. 

             4.5        
Information. The Investor has been furnished (i) with all
requested materials relating to the business, finances, and operations of the
Company; (ii) with information deemed material to making an informed investment
decision; and (iii) with additional requested information necessary to verify
the accuracy of any documents furnished to it by the Company. Parties
representing the Investor have been afforded the opportunity to ask questions of
the Company and its management and to receive answers concerning the terms and
conditions of this offering.

             4.6        
Documents. Parties representing the Investor have had access on
the Commission website (www.sec.gov) to the
SEC Reports, including the exhibits thereto. The Investor has relied upon the
information contained therein and has not been furnished any other material
documents, literature, memorandum, or prospectus. 

             4.7        
Knowledge and Experience in Business and Financial Matters. Each
of the parties representing the Investor has such knowledge and experience in
business and financial matters that he is capable of evaluating the risks of the
prospective investment. The financial capacity of the Investor is of such
proportion that the total cost of its commitment in the First and Second Tranche
Units would not be material when compared with its total financial capacity.

             4.8        
No Directed Selling Efforts. The Investor has not engaged, nor
is it aware that any party has engaged, and the Investor will not engage or
cause any third party to engage, in any directed selling efforts1 (as
such term is defined in Regulation S) in the United States with respect to the
First or Second Tranche Units, the Bonus Warrants, or the Warrant Shares. 

             4.9        
Non-U.S. Person Status. The Investor: (i) is domiciled and has
its principal place of business outside the United States; (ii) is not a U.S.
Person and is not acquiring the First or Second Tranche Units, the Bonus
Warrants, or the Warrant Shares for the account or benefit of any U.S. Person;
and (iii) at the time of the purchase of these securities, the Investor or
persons acting on its behalf in connection therewith will be located outside the
United States. 

________________________________________
1 In
general, “directed selling efforts” means any activity undertaken for the
purpose, or that could reasonably be expected to have the effect, of
conditioning the market in the United States for the securities of the issuer.
Such activity includes placing an advertisement in a publication “with a general
circulation in the United States” that refers to the offering of the securities
being made in reliance upon this Regulation S. 

9 

             4.10        
Not a Distributor. The Investor is not a
distributor2 (as defined in Regulation S) or a dealer (as defined in
the Securities Act). 

             4.11        
Transfer Limitations. The Investor acknowledges that the Company
shall make a notation in its stock books regarding the restrictions on transfer
set forth in this MOU and shall transfer the Unit Shares, the Warrants and the
Warrant Shares on the books of the Company only to the extent consistent
therewith. In particular, the Investor acknowledges that the Company shall
refuse to register any transfer of the Unit Shares, the Warrants or the Warrant
Shares not made in accordance with the provisions of Regulation S, pursuant to
registration under the Securities Act or pursuant to an available exemption from
registration. 

             4.12        
Restrictive Legend. The Investor understands and agrees
that each certificate held by it representing the Unit Shares, the Warrants and
the Warrant Shares or any other securities issued in respect of the First and
Second Tranche Units or Warrants shall bear substantially the following legend:

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, EXERCISED,
PLEDGED OR HYPOTHECATED EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S
PROMULGATED UNDER THE SECURITIES ACT, PURSUANT TO REGISTRATION UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING
TRANSACTIONS INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. THIS CERTIFICATE MUST BE
SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE
SALE, PLEDGE, HYPOTHECATION OR ANY OTHER TRANSFER OF ANY INTEREST IN ANY OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE. 

             4.13        
Compliance with Local Jurisdiction Laws. The Investor has
satisfied as to the full observance of the laws of its jurisdiction in
connection with this transaction, including: (i) the legal requirements within
its jurisdiction for the purchase of the First and Second Tranche Units, the
Bonus Warrants or the Warrant Shares, (ii) any foreign exchange restrictions
applicable to such purchases, (iii) any governmental or other consents that may
need to be obtained and (iv) the income tax and other tax consequences, if any,
that may be relevant to the purchase, holding, redemption, sale or transfer of
such securities. The Investor’s subscription and payment for, and its continued
beneficial ownership of, these securities will not violate any applicable
securities or other laws of its jurisdiction. 

5.        
OTHER AGREEMENTS OF THE PARTIES. 

             5.1        
Access to Information. The Investor and its authorized
Representatives shall have full access during normal business hours to all
properties, books, records, contracts, and documents of the Company, and the
Company shall furnish or cause to be furnished to the Investor and its
authorized Representatives all information with respect to its affairs and
business the Investor may reasonably request. The Investor and any authorized
Representative granted access to such information shall enter into the Company’s standard nondisclosure agreement prior to
receiving or being granted access to such information. 

_____________________________________
2
“Distributor” means any underwriter, dealer, or other person who
participates, pursuant to a contractual arrangement, in the distribution of the
securities. 

10 

             5.2        
New Directors. Prior to the First Closing the Investor will
furnish material information of the Director Designees to be appointed as
directors of the Company at the First Closing. Prior to First Closing the Board
of Directors will increase the number of directors to seven persons, will
furnish the resignation of one sitting director, and shall appoint the Director
Designees to fill the three vacancies created by the increase in the number of
directors and the resignation of the sitting director to be effective
immediately upon completion of the First Closing. The Board of Directors shall
appoint the Director Designees unless the Board of Directors reasonably
determines that the Board Designees would not be qualified to serve as directors
of the Company pursuant to standards common to U.S. public companies subject to
the reporting requirements of the 1934 Act. The Investor reserves the right to
terminate this MOU if all of the Director Designees selected by it are not
elected or appointed as set forth above. The Director Designees will be covered
by the Company’s current D&O insurance policy effective upon appointment as
directors of the Company. In the event the Second Closing does not occur or this
Agreement is terminated prior to the Second Closing, the Investor shall cause
one of the Director Designees to resign and permit the remaining directors to
appoint the replacement director. 

             5.3        
Syndication of Unit Sales. The Investor may syndicate the
purchase of the First or Second Tranche Units through one or more additional
investors who meet the requirements of this MOU and who provide signed
representation forms as set forth in Exhibit C. 

             5.4        
Exclusive Dealing. During the term of this Agreement,
the Company shall not, directly or indirectly, through any Representative or
otherwise, enter into another agreement or proposal with any other person to
provide funding for the Company through the issuance of equity or debt
securities (collectively, an “Alternative Transaction”); provided,
however, that the Company may continue to honor existing funding agreements and
may continue to engage in discussions and negotiations with third parties to
secure such funding in the event the First or Second Closings do not occur. Upon
receipt of a definitive proposal to effect an Alternative Transaction, the
Company will immediately notify the Investor of the Alternative Transaction
proposal. Notwithstanding any Alternative Transaction, the Company shall be
obligated to proceed with the closing of this MOU unless or until this MOU is
otherwise terminated as provided herein. Notwithstanding the foregoing, if the
Environmental Impact Study is not completed by March 31, 2014, the Investor
agrees either (i) to provide operating funds for the Company through the Second
Closing Date such that the Company shall maintain at least $500,000 in its
operating account, or (ii) to permit the Company to seek interim funding from
third parties pending the Second Closing. 

            
5.5        
Patriot Act Compliance.

                             (a)        
The Investor acknowledges that due to anti-terrorism and anti-money laundering
regulations, the Company acting through any Representative, may require further
documentation verifying the Investor’s identity and the source of funds used to
purchase the Units. To comply with applicable U.S. legislation and regulations,
including but not limited to the International Anti-Money Laundering and
Financial Anti-Terrorism Abatement Act of 2001 (Title III of the USA PATRIOT
Act), the Investor agrees that all payments to the Company by the Investor or
any syndicated purchaser and all distributions to Investor from the Company will
only be made in the name of the Investor or the syndicated purchaser and to and
from a bank account of a bank based or incorporated in or formed under the laws
of the United States or a bank that is not a “foreign shell bank” within the
meaning of the U.S. Bank Secrecy Act (31 U.S.C. § 5311 et seq.), as amended, and
the regulations promulgated thereunder by the U.S. Department of the Treasury,
as such regulations may be amended from time to time. 

11 

                             (b)        
The Investor further agrees to provide the Company at any time that Investor is
a stockholder of the Company with such information or certification as the
Company determines to be necessary or appropriate to verify compliance with the
anti-terrorism and anti-money laundering regulations of any applicable
jurisdiction or to respond to requests for information concerning the identity
of the Investor or any person directly or indirectly controlling, controlled by
or under common control with the Investor from any governmental authority,
self-regulatory organization or financial institution in connection with the
Company’s compliance procedures with respect to anti-terrorism and anti-money
laundering regulations and to update such information as necessary. Such
information may include, but not be limited to, the name, address, telephone
number, date of birth, and Social Security or taxpayer identification number of
any such individual. Identity may be verified using a current valid passport or
other such current valid government-issued identification (e.g., a driver’s
license). 

                             (c)        
The Investor certifies that it is not identified as a specially designated
national or blocked person, or as affiliated with any such person, entity or
organization on any list maintained by governmental authorities relating to
anti-terrorism or anti-money laundering, including but not limited to lists
maintained by the United States Treasury Department’s Office of Foreign Asset
Control. 

                             (d)        
The Investor understands that the information contained herein may be disclosed
to the United States Government by the Company. 

             5.6        
Expenses. Except as otherwise expressly provided herein,
each party to this MOU shall bear its own respective expenses incurred in
connection with the negotiation and preparation of this MOU, in the consummation
of the transactions contemplated hereby, and in connection with all duties and
obligations required to be performed by each of them under this MOU. 

             5.7        
Brokerage. The Company may engage licensed selling
agents or consultants to assist in this transaction for which the Company will
be solely responsible for payment of fees not to exceed 7% of the total proceeds
of the First and Second Tranches. 

             5.8        
Compliance with Regulation S. The Investor agrees that
with respect to the Unit Shares, the Warrants and the Warrant Shares, until the
expiration of the Restricted Period (i) neither it, its agents or its
Rrepresentatives will not solicit offers to buy, offer for sale or sell any of
these securities, or any beneficial interest therein, in the United States or to
or for the account of a U.S. Person during the Restricted Period, unless the
transaction is otherwise exempt under the Securities Act; (ii) these securities
will be offered and sold only if such offer and sale is made in compliance with
the terms of this MOU and Regulation S; and (iii) it will not engage in hedging
transactions with regard to these securities unless in compliance with the
Securities Act. The Investor acknowledges that the foregoing restrictions are
binding upon subsequent transferees of these securities, except for transferees
pursuant to an effective registration statement or valid exemption from the
registration requirements of the Securities Act. The Investor further agrees to
comply with procedures implemented by the Company to ensure that the Warrants
may not be exercised within the United States and that the Warrant Shares may
not be delivered within the United States upon exercise, other than in offerings
deemed to meet the definition of “offshore transaction” pursuant to Rule 902(h),
unless registered under the Securities Act or an exemption from such
registration is available. The Investor further agrees that any person
exercising a Warrant shall furnish the Company with the following: (i) written
certification that the person is not a U.S. Person and the Warrant is not being
exercised on behalf of a U.S. Person; or (ii) a written opinion of counsel to
the effect that the Warrant and the Warrant Shares delivered upon exercise
thereof have been registered under the Act or are exempt from registration
thereunder. 

             5.9        
Operations Prior to Second Closing. Through the Second Closing
Date the Company shall continue to implement its current business plan to
complete the Environment Impact Study, obtain all necessary mining permits, complete the Cerro Blanco
feasibility study, and secure funding or a joint venture partner to construct
and operate the Cerro Blanco mine, and neither the Investor nor the Director
Designees shall authorize or permit the Company to alter its current business
operations, change its business plan, or dispose of any assets except in the
ordinary course of business. 

12 

             5.10        
Further Actions. Each of the parties hereto shall take all such
further action, and execute and deliver such further documents, as may be
necessary to carry out the transactions contemplated by this MOU. 

6.        
CONDITIONS PRECEDENT TO CLOSING. 

             6.1        
Conditions Precedent to the Obligations of the Investor to Purchase the
Units. The obligation of the Investor to acquire the First and
Second Tranche Units at each Closing is subject to the satisfaction or waiver by
the Investor, at or before the Closing, of each of the following conditions:

                             (a)        
Representations and Warranties. The representations and warranties of the
Company contained herein shall be true and correct in all material respects as
of the date when made and as of the First or Second Closing Date as though made
on and as of such date; 

                             (b)        
Performance. The Company shall have performed, satisfied and complied in
all material respects with all covenants, agreements and conditions required by
this MOU to be performed, satisfied or complied with by it at or prior to the
First or Second Closing, as applicable; 

                             (c)        
No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits
the consummation of any of the transactions contemplated by this MOU;

                             (d)        
Material Adverse Effect. Since the date hereof, there shall not be any
event, occurrence or condition that has had or could reasonably be expected to
have a Material Adverse Effect on the Company. 

             6.2        
Conditions Precedent to the Obligations of the Company to Sell the
Units. The obligation of the Company to sell the First and Second
Tranche Units at each Closing is subject to the satisfaction or waiver by the
Company, at or before the Closing, of each of the following conditions: 

                             (a)        
Representations and Warranties. The representations and warranties of the
Investor contained herein shall be true and correct in all material respects as
of the date when made and as of the First or Second Closing Date, as applicable,
as though made on and as of such date; 

                             (b)        
Performance. The Investor shall have performed, satisfied and complied in
all material respects with all covenants, agreements and conditions required by
this MOU to be performed, satisfied or complied with by the Investor at or prior
to the First or Second Closing, as applicable; 

                             (c)        
No Injunction. No statute, rule, regulation, executive order, decree,
ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction that prohibits
the consummation of any of the transactions contemplated by this MOU. 

13 

7.        
TERMINATION. 

             7.1        
The parties may terminate this MOU at any time upon mutual consent in writing.
The Investor may terminate this MOU prior to the First Closing if the Investor
reasonably determines based upon its due diligence review of the Company that
the transaction would not be in its best interests. The Company may terminate
this MOU if any payment for the First or Second Closings is not received on or
before the designated Closing dates for either of the subdivisions of the First
Closing or for the Second Closing. Either party may terminate this MOU if all of
the conditions contained in Sections 6.1 or 6.2, as applicable, have not been
satisfied by the First or Second Closing Date, as applicable; provided, however,
that the party seeking such termination shall not be in breach of any
representation, warranty or covenant which has caused the failure of any
condition of the other party to be satisfied. In the event of such termination
by the Company, the Investor shall have no obligation to purchase any Units from
the Company and the Company shall have no further obligation to sell to the
Investor any Units; provided, however, that if the MOU is terminated after the
First Closing but prior to the Second Closing, such termination shall not affect
the validity of the transaction consummated at the First Closing. 

8.        
MISCELLANEOUS. 

             8.1        
Survival of Provisions. The representations and warranties set
forth in Article 4 of this MOU shall survive the execution and delivery of this
MOU indefinitely, and the other representations and warranties set forth in this
MOU shall survive for a period of twelve (12) months following the Second
Closing Date regardless of any investigation made by or on behalf of the Company
or the Investor. The covenants made in this MOU shall survive the closing of the
transactions described herein and remain operative and in full force and effect
regardless of acceptance of any of the Units and payment therefor.

             8.2        
Notices. Any notice, demand, request, waiver or other
communication required or permitted to be given hereunder shall be in writing or
electronic format, as applicable, and shall be effective (i) upon delivery in
person (including by reputable express courier service) at the address set forth
below; (ii) upon delivery by facsimile (as verified by a printout showing
satisfactory transmission) at the facsimile number designated below (if sent on
a business day during normal business hours where such notice is to be received
and if not, on the first business day following such delivery where such notice
is to be received); (iii) by electronic mail (as verified by a printout showing
a read-receipt by the recipient) at the electronic mail address set forth below
(if sent on a business day during normal business hours where such notice is to
be received and if not, on the first business day following such delivery where
such notice is to be received); or (iv) upon three business days after mailing
by registered or certified mail, return receipt requested, addressed to the
address set forth below. Any party hereto may from time to time change its
physical or electronic address or facsimile number for notices by giving notice
of such changed address or number to the other party hereto in accordance
herewith. 

            
If to the Company to: 

White Mountain Titanium Corporation

Augusto Leguia 100, Oficina 1401, 
Las Condes, Santiago, Chile.

Tel:    +00562 6571 800 
Fax:    +00562
6571 809 
e-mail mpk@wmtcorp.com
Attention: Michael P. Kurtanjek,
President 

14 

            
With a copy (which shall not constitute notice) to: 

Ronald N. Vance 
The Law Office of
Ronald N. Vance & Associates, P.C. 
1656 Reunion Avenue 
Suite 250

South Jordan, UT 84095 
Tel :    (801) 446-8802 
Fax
:    (801) 446-8803 
e-mail ron@vancelaw.us 

            
If to the Investor, to: 

Grand Agriculture Investment
Limited 
Unit C&D 9/F, Neich Tower 
128 Gloucester Road,
Wanchai, Hong Kong 
Tel:    +138-2320-4232

Fax:    ________________________
e-mail jyworkgroup@126.com 
Attention: Kin Wong, Chief
Executive Officer

            
With a copy (which shall not constitute notice) to: 

______________________________________
______________________________________
______________________________________
Tel:    
_________________________________
Fax:    
_________________________________
e-mail 
_________________________________

             8.3        
Governing Law; Venue; Waiver of Jury Trail. ALL QUESTIONS
CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS
MOU SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS
OF THE STATE OF NEW YORK. THE COMPANY AND THE INVESTOR HEREBY IRREVOCABLY SUBMIT
TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE
CITY OF NEW YORK, BOROUGH OF MANHATTAN FOR THE ADJUDICATION OF ANY DISPUTE
BROUGHT BY THE COMPANY OR THE INVESTOR HEREUNDER, IN CONNECTION HEREWITH OR WITH
ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT
TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY
WAIVE, AND AGREE NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE
COMPANY OR THE INVESTOR, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE
JURISDICTION OF ANY SUCH COURT, OR THAT SUCH SUIT, ACTION OR PROCEEDING IS
IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND
CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY
MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY
(WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES
TO IT UNDER THIS MOU AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT
SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED
TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.
THE COMPANY AND THE INVESTOR HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY. 

15 

             8.4        
Legal Expenses. If any legal action or other proceeding is
brought for the enforcement of this MOU, or because of an alleged dispute,
breach, default, or misrepresentation in connection with any of the provisions
of this MOU, the successful or prevailing party or parties will be entitled to
recover reasonable attorneys’ fees and other costs incurred in that action or
proceeding, in addition to any other relief to which it or they may be entitled.

             8.5        Binding on Successors. This MOU will be binding
on, and will inure to the benefit of, the parties to it and their respective
heirs, legal representatives, successors, and assigns. 

             8.6        
Amendment. Neither this MOU nor any provision
hereof may be amended, changed, waived, terminated (except pursuant to Article
6) or discharged orally, but only by an instrument in writing signed by the
party against whom enforcement of the amendment, change, waiver, termination or
discharge is sought. 

             8.7        
Exhibits. Each of the appendices, exhibits or schedules
referenced in this MOU is annexed hereto and is incorporated herein by this
reference and expressly made a part hereof. 

             8.8        
Pronouns. Whenever the context might require, any
pronouns used herein shall include the corresponding masculine, feminine or
neuter forms, and the singular forms of nouns and pronouns shall include the
plural, and vice versa. 

             8.9        
Captions. The captions appearing herein are for
convenience of reference only and in no way define, limit or affect the scope or
substance of any section hereof. 

             8.10        
Time. All references herein to periods of days
are to calendar days, unless expressly provided otherwise. Where the time period
specified herein would end on a weekend or holiday, the time period shall be
deemed to end on the next Business Day. 

             8.11        
Entire MOU. This MOU constitutes the entire agreement
between the parties hereto and supersedes all prior agreements and
understandings, whether written or oral relating to the subject matter hereof.

             8.12        
Severability. In case any provision hereof shall
be held by a court to be invalid, illegal, or otherwise unenforceable, such
provision shall be restated to reflect as nearly as possible the original
intentions of the parties hereto in accordance with applicable law, and the
validity, legality, and enforceability of the remaining provisions shall not be
affected or impaired thereby. 

             8.13        
Counterparts. This MOU may be executed in two or
more counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument. 

             8.14        
Full Knowledge. By their signatures, the parties
acknowledge that they have carefully read and fully understand the terms and
conditions of this MOU, that each party has had the benefit of separate counsel,
or has been advised to obtain separate counsel, and that each party has freely
agreed to be bound by the terms and conditions of this MOU. To the extent that a
party elects not to consult with such counsel, the party hereby waives any
defense to inadequate representation by counsel. 

16 

            
8.15        
Construction. This MOU shall be construed as though all
parties had drafted it.

             8.16        
Non-Exclusivity of Remedies. The rights and remedies of the
parties hereto shall not be mutually exclusive, and the exercise of one or more
of the provisions of this MOU shall not preclude the exercise of any other
provision.

             8.17        
Remedies. In addition to being entitled to exercise all rights
provided herein or granted by law, including recovery of damages, each of the
parties hereto will be entitled to specific performance. Each of the parties
agrees that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations described in the foregoing
sentence and hereby agrees to waive in any action for specific performance of
any such obligation the defense that a remedy at law would be adequate. 

             8.18        
Confidentiality. Each party agrees that the existence of
this MOU and its terms and conditions shall be kept strictly confidential and
shall not be disclosed to any person except as may be required by law,
regulation, stock exchange or legal process.

             8.19        
English Language. This MOU has been prepared in the English
language and the English language shall control its interpretation. All
consents, notices, reports and other written documents to be delivered or
provided by a party hereto under this MOU shall be in the English language, and
in the event of any conflict between the provisions of any document and the
English language translation thereof, the terms of the English language
translation shall control. 

[SIGNATURE PAGE FOLLOWS] 

17 

SIGNATURE PAGE 

             IN
WITNESS WHEREOF, each of the parties hereto has executed this MOU the respective
day and year set forth below. 

	COMPANY: 	White Mountain Titanium Corporation
  

 

	Date: December 3, 2013 	By:	/s/ Michael P. Kurtanjek 
	 	 	Michael P. Kurtanjek, Chief
      Executive Officer 

 

	INVESTOR: 	Grand Agriculture Investment Limited
  

 

	Date: December 4, 2013 	By:	/s/ Kin Wong 
	 	 	Kin Wong, Chief Executive Officer
    

18 

EXHIBIT A 

FIRST TRANCHE WARRANT 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT
BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED EXCEPT IN ACCORDANCE
WITH THE PROVISIONS OF REGULATION S PROMULGATED UNDER THE SECURITIES ACT,
PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS INVOLVING THE SECURITIES
REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES
ACT. THIS CERTIFICATE MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT
AS A CONDITION PRECEDENT TO THE SALE, PLEDGE, HYPOTHECATION OR ANY OTHER
TRANSFER OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED BY THIS
CERTIFICATE. 

WHITE MOUNTAIN TITANIUM CORPORATION

FIRST TRANCHE WARRANT
TO PURCHASE COMMON
STOCK 

Warrant No.: W-____ 
Number of Shares:
_________________
Date of Issuance: ___________________, 201____ (the
“Issuance Date”) 

             White
Mountain Titanium Corporation, a Nevada corporation (the “Company”),
hereby certifies that, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, ____________________, the
registered holder hereof or its permitted assigns (the “Holder”), is
entitled, subject to the terms set forth below, to purchase from the Company, at
the Exercise Price (as defined below) then in effect, upon surrender of this
Warrant to Purchase Common Stock (including all Warrants to Purchase Common
Stock issued in exchange, transfer or replacement hereof, the “Warrant”),
at any time or times on or after the date hereof, but not after 11:59 P.M., New
York Time, on the Expiration Date (as defined below),
_______________________(_________) fully paid nonassessable shares of Common
Stock (as defined below) (the “Warrant Shares”). Except as
otherwise defined herein, capitalized terms in this Warrant shall have the
meanings set forth in Section 12. This Warrant is one of the First Tranche
Warrants issued pursuant to the Binding Memorandum of Understanding dated
November ___, 2013, between the Company and Grand Agriculture Investment
Limited. 

            
1.         
 EXERCISE OF WARRANT. 

                             1.1        
Mechanics of Exercise. Subject to the terms and conditions hereof, this
Warrant may be exercised by the Holder on any day, in whole or in part, by (i)
delivery of a written notice, in the form attached hereto as Exhibit A
(the “Exercise Notice”), of the Holder’s election to exercise this
Warrant and (ii) payment to the Company of an amount equal to the applicable
Exercise Price multiplied by the number of Warrant Shares as to which this
Warrant is being exercised (the “Aggregate Exercise Price”) in cash or
wire transfer of immediately available funds. The Holder shall not be required
to deliver the original Warrant in order to effect an exercise
hereunder; provided, however, that the Holder shall covenant in the
Exercise Notice, that it will deliver the original Warrant to the Company within
five (5) Business Days of such exercise. Execution and delivery of the Exercise
Notice with respect to less than all of the Warrant Shares shall have the same
effect as cancellation of the original Warrant and issuance of a new Warrant
evidencing the right to purchase the remaining number of Warrant Shares. On or
before the first Business Day following the date on which the Company has
received each of the Exercise Notice and the Aggregate Exercise Price (the
“Exercise Delivery Documents”), the Company shall transmit by facsimile
an acknowledgment of confirmation of receipt of the Exercise Delivery Documents
to the Holder and the Company’s transfer agent (the “Transfer Agent”). On
or before the third Business Day following the date on which the Company has
received all of the Exercise Delivery Documents (the “Share Delivery
Date”), the Company shall (X) provided that the Transfer Agent is
participating in The Depository Trust Company (“DTC”) Fast Automated
Securities Transfer Program, upon the request of the Holder, credit such
aggregate number of shares of Common Stock to which the Holder is entitled
pursuant to such exercise to the Holder’s or its designee’s balance account with
DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the
Transfer Agent is not participating in the DTC Fast Automated Securities
Transfer Program, issue and dispatch by overnight courier to the address as
specified in the Exercise Notice, a certificate, registered in the name of the
Holder or its designee, for the number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise. Upon delivery of the Exercise
Notice and Aggregate Exercise Price referred to in clause (ii)(A) above the
Holder shall be deemed for all corporate purposes to have become the holder of
record of the Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date of delivery of the certificates evidencing
such Warrant Shares. If this Warrant is submitted in connection with any
exercise pursuant to this Section 1(a) and the number of Warrant Shares
represented by this Warrant submitted for exercise is greater than the number of
Warrant Shares being acquired upon an exercise, then the Company shall as soon
as practicable and in no event later than three (3) Business Days after any
exercise and at its own expense, issue a new Warrant (in accordance with Section
5(d)) representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant, less the
number of Warrant Shares with respect to which this Warrant is exercised. No
fractional shares of Common Stock are to be issued upon the exercise of this
Warrant, but rather the number of shares of Common Stock to be issued shall be
rounded up to the nearest whole number. The Company shall pay any and all taxes,
including without limitation, all documentary stamp, transfer or similar taxes,
or other incidental expense that may be payable with respect to the issuance and
delivery of Warrant Shares upon exercise of this Warrant. 

                             1.2        
Exercise Price. For purposes of this Warrant, “Exercise Price”
means US$0.45 per share, subject to adjustment as provided herein. 

                             1.3        
Disputes. In the case of a dispute as to the determination of
the Exercise Price or the arithmetic calculation of the Warrant Shares, the
Company shall promptly issue to the Holder the number of Warrant Shares that are
not disputed and resolve such dispute in accordance with Section 10. 

                             1.4        
No Fractional Shares or Scrip. No fractional shares or scrip
representing fractional shares shall be issued upon the exercise of this
Warrant. In lieu of any fractional share to which the Holder would otherwise be
entitled, the Company shall make a cash payment equal to the fair market value
of such fractional share.

                            
1.5         Compliance with
Securities Laws.

                                             (a)        
The Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant
and the Common Stock to be issued upon exercise hereof are being acquired solely
for the Holder’s own account and not as a nominee for any other party; and for
investment, and that the Holder will not offer, sell or otherwise dispose of this
Warrant or any Common Stock to be issued upon exercise hereof except under
circumstances that will not result in a violation of the Securities Act or any
state securities laws. Upon exercise of this Warrant, the Holder shall, if
requested by the Company, confirm in writing, in a form satisfactory to the
Company, that the Common Stock so purchased are being acquired solely for the
Holder’s own account and not as a nominee for any other party, for investment,
and not with a view toward distribution or resale.

20

                                             (b)        
This Warrant and all Common Stock issued upon exercise hereof unless registered
under the Securities Act shall be stamped or imprinted with a legend in
substantially the following form (in addition to any legend required by state
securities laws):

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR
HYPOTHECATED EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S
PROMULGATED UNDER THE SECURITIES ACT, PURSUANT TO REGISTRATION UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING
TRANSACTIONS INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. THIS CERTIFICATE MUST BE
SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE
SALE, PLEDGE, HYPOTHECATION OR ANY OTHER TRANSFER OF ANY INTEREST IN ANY OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE. 

            
2.         
 ORGANIC CHANGE.

                             Any
recapitalization, reorganization, reclassification, consolidation, merger, sale
of all or substantially all of the Company’s assets to another Person or other
transaction, in each case which is effected in such a way that holders of Common
Stock are entitled to receive securities or assets with respect to or in
exchange for Common Stock is referred to herein as an “Organic Change.”
Prior to the consummation of any (i) sale of all or substantially all of the
Company’s assets to an acquiring Person or (ii) other Organic Change following
which the Company is not a surviving entity, the Company will secure from the
Person purchasing such assets or the Person issuing the securities or providing
the assets in such Organic Change (in each case, the “Acquiring Entity”)
a written agreement to deliver to the Holder in exchange for this Warrant, a
security of the Acquiring Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant and reasonably satisfactory to the
holder of this Warrant (including an adjusted exercise price equal to the value
for the Common Stock reflected by the terms of such consolidation, merger or
sale, and exercisable for a corresponding number of shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant), if the value so reflected is less
than the Exercise Price in effect immediately prior to such consolidation,
merger or sale). In the event that an Acquiring Entity is directly or indirectly
controlled by a company or entity whose common stock or similar equity interest
is listed, designated or quoted on a securities exchange or trading market, the
Holder may elect to treat such Person as the Acquiring Entity for purposes of
this Section 2. Notwithstanding the foregoing, at the Holder’s option and
request, the Acquiring Entity shall purchase the Warrant from such Holder for a
purchase price, payable in cash within five (5) Business Days after such request
(or, if later, on the effective date of the Organic Change), equal to the value
of the remaining unexercised portion of this Warrant on the date of such
request, which value shall be computed using the Black-Scholes option pricing
model with such assumptions and inputs as are reasonably satisfactory to the
Company. The terms of any agreement pursuant to which a Organic Change is
effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section
2 and insuring that the Warrants (or any such replacement security) will be
similarly adjusted upon any subsequent transaction analogous to an Organic
Change. Prior to the consummation of any other Organic Change, the Company shall
make appropriate provision to insure that the Holder thereafter will have the
right to acquire and receive in lieu of or in addition to (as the case may be)
the shares of Common Stock immediately theretofore acquirable and receivable
upon the exercise of this Warrant (without regard to any limitations on the
exercise of this Warrant), such shares of stock, securities or assets that would
have been issued or payable in such Organic Change with respect to or in
exchange for the number of shares of Common Stock which would have been
acquirable and receivable upon the exercise of this Warrant as of the date of
such Organic Change (without regard to any limitations on the exercise of this
Warrant).

21

                             If,
prior to the exercise of this Warrant, the Company shall have effected one or
more stock split-ups, stock dividends or other increases or reductions of the
number of shares of its Common Stock outstanding without receiving reasonable
compensation therefor in money, services, or property, the number of shares of
Common Stock subject to this Warrant shall, (i) if a net increase shall have
been effected in the number of outstanding shares of Common Stock, be
proportionately increased, and the cash consideration payable per share shall be
proportionately reduced, and, (ii) if a net reduction shall have been effected
in the number of outstanding shares of Common Stock, be proportionately reduced
and the cash consideration payable per share be proportionately increased.

             3.         
 NONCIRCUMVENTION. The Company hereby covenants and
agrees that the Company will not, by amendment of its Articles of Incorporation
or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities, or any other voluntary action, avoid
or seek to avoid the observance or performance of any of the terms of this
Warrant, and will at all times in good faith carry out all the provisions of
this Warrant and take all action as may be required to protect the rights of the
Holder. 

             4.          
WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as
otherwise specifically provided herein, the Holder, solely in such Person’s
capacity as a holder of this Warrant, shall not be entitled to vote or receive
dividends or be deemed the holder of shares of the Company for any purpose, nor
shall anything contained in this Warrant be construed to confer upon the Holder,
solely in such Person’s capacity as the Holder, any of the rights of a
shareholder of the Company or any right to vote, give or withhold consent to any
corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, conveyance or otherwise), receive notice of
meetings, receive dividends or subscription rights, or otherwise, prior to the
issuance to the Holder of the Warrant Shares which such Person is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to
purchase any securities (upon exercise of this Warrant or otherwise) or as a
stockholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 4, the Company will
provide the Holder with copies of the same notices and other information given
to the stockholders of the Company generally, contemporaneously with the giving
thereof to the stockholders. 

            
5.          
REISSUANCE OF WARRANTS. 

                             5.1        
Transfer of Warrant. If this Warrant is to be transferred, the
Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in
accordance with Section 5(d)), registered as the Holder may request,
representing the right to purchase the number of Warrant Shares being
transferred by the Holder and, if less then the total number of Warrant Shares
then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 5(d)) to the Holder
representing the right to purchase the number of Warrant Shares not being
transferred. 

22

                             5.2        
Lost, Stolen or Mutilated Warrant. Upon receipt by the Company
of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant, and, in the case of loss, theft or
destruction, of any indemnification undertaking by the Holder to the Company in
customary form and, in the case of mutilation, upon surrender and cancellation
of this Warrant, the Company shall execute and deliver to the Holder a new
Warrant (in accordance with Section 5(d)) representing the right to purchase the
Warrant Shares then underlying this Warrant. 

                             5.3        
Warrant Exchangeable for Multiple Warrants. This Warrant is
exchangeable, upon the surrender hereof by the Holder at the principal office of
the Company, for a new Warrant or Warrants (in accordance with Section 5(d))
representing in the aggregate the right to purchase the number of Warrant Shares
then underlying this Warrant, and each such new Warrant will represent the right
to purchase such portion of such Warrant Shares as is designated by the Holder
at the time of such surrender; provided, however, that no Warrants for
fractional shares of Common Stock shall be given. 

                             5.4        
Issuance of New Warrants. Whenever the Company is required to
issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on
the face of such new Warrant, the right to purchase the Warrant Shares then
underlying this Warrant (or in the case of a new Warrant being issued pursuant
to Section 5(a) or Section 5(c), the Warrant Shares designated by the Holder
which, when added to the number of shares of Common Stock underlying the other
new Warrants issued in connection with such issuance, does not exceed the number
of Warrant Shares then underlying this Warrant), (iii) except for new warrants
issued pursuant to section 5(a), shall have an issuance date, as indicated on
the face of such new Warrant, which is the same as the Issuance Date, and (iv)
shall have the same rights and conditions as this Warrant. 

             6.          
NOTICES. All notices, demands or other communications to
be given or delivered under or by reason of the provisions of this Warrant shall
be in writing and shall be deemed to have been given when delivered personally
to the recipient, sent to the recipient by facsimile transmission, sent to the
recipient by email, sent to the recipient by reputable express courier service
(charges prepaid), or three (3) Business Days after being mailed to the
recipient by certified or registered mail, return receipt requested and postage
prepaid. Such notices, demands, and other communications will be sent to the
Holder at the address or number indicated on the records of the Company and to
the principal executive offices of the Company, or to such other address or to
the attention of such other person as the recipient party has specified by prior
written notice to the sending party. 

             7.          
AMENDMENT AND WAIVER. Except as otherwise provided
herein, the provisions of this Warrant may be amended and the Company may take
any action herein prohibited, or omit to perform any act herein required to be
performed by it, only if the Company has obtained the written consent of the
holders of these Warrants representing at least a majority of the shares of
Common Stock obtainable upon exercise of these Warrants then outstanding;
provided, however, that the Company may reduce the Exercise Price or extend the
Expiration Date without the prior consent of the holders of these Warrants. 

             8.          
GOVERNING LAW; VENUE; WAIVER OF JURY TRAIL. ALL
QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION
OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK. THE COMPANY AND THE WARRANT HOLDER
HEREBY IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE STATE
AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN FOR THE
ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR THE WARRANT HOLDER
HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR
DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE
TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN
ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR THE WARRANT HOLDER, ANY
CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT,
OR THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY
IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING
SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA
REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY)
TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS WARRANT AND
AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS
AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY
ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND THE
INVESTOR HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY. 

23

             9.       
   CONSTRUCTION; HEADINGS. This Warrant shall
be deemed to be jointly drafted by the Company and the Holder and shall not be
construed against any person as the drafter hereof. The headings of this Warrant
are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant. 

            
10.        
REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The
remedies provided in this Warrant shall be cumulative and in addition to all
other remedies available under this Warrant at law or in equity (including a
decree of specific performance and/or other injunctive relief), and nothing
herein shall limit the right of the Holder to pursue actual damages for any
failure by the Company to comply with the terms of this Warrant. The Company
acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to the holder of this Warrant and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the
event of any such breach or threatened breach, the Holder shall be entitled, in
addition to all other available remedies, to an injunction restraining any
breach, without the necessity of showing economic loss and without any bond or
other security being required. 

             11.        
TRANSFER. This Warrant may not be offered for sale,
sold, transferred or assigned without the consent of the Company.

             12.          
CERTAIN DEFINITIONS. For purposes of this Warrant, the
following terms shall have the following meanings: 

                             12.1        
“Business Day” means any day except Saturday, Sunday and any day
which is a federal or Canadian legal holiday or a day on which banking
institutions in the State of New York or the Province of British Columbia are
authorized or required by law or other governmental action to close. 

                             12.2        
“Common Stock” means (i) the Company’s common stock, par value
$0.001 per share, and (ii) any capital stock into which such Common Stock shall
have been changed or any capital stock resulting from a reclassification of such
Common Stock. 

24

                             12.3        
“Expiration Date” means December 31, 2016, or, if such date falls
on a day other than a Business Day or on which trading does not take place on
the Principal Market (a “Holiday”), the next date that is not a
Holiday.

                             12.4        
“Person” means an individual, a limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization, any
other entity and a government or any department or agency thereof. 

                             12.5        
“Principal Market” means the principal securities exchange or trading
market on which the Common Stock is listed and trades. 

25

             IN
WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common
Stock to be duly executed as of the Issuance Date set out above. 

WHITE MOUNTAIN TITANIUM CORPORATION

 

	 	By:	 
	 	 	Name: 
	 	 	Title: 

EXHIBIT A 

EXERCISE NOTICE 

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK 

WHITE MOUNTAIN TITANIUM CORPORATION 

             The
undersigned holder hereby exercises the right to purchase ___________ of the
shares of Common Stock (“Warrant Shares”) of White Mountain Titanium
Corporation, a Nevada corporation (the “Company”), evidenced by the
attached Warrant to Purchase Common Stock (the “Warrant”). Capitalized
terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant. 

             1.
Payment of Exercise Price. The holder shall pay the Aggregate Exercise Price in
the sum of $___________________ to the Company in accordance with the terms of
the Warrant. 

             2.
Accredited Investor. The holder is an “accredited investor” as defined in Rule
501(c) under the Securities Act. 

             3.
Delivery of Warrant Shares. The Company shall deliver to the holder __________
Warrant Shares in accordance with the terms of the Warrant. 

             4.
Delivery of Warrant. The Holder shall deliver the original Warrant to the
Company within five (5) Business Days from the date hereof. 

             [5.
The Holder hereby represents that contemporaneous with the delivery of this
exercise notice, that the Holder has sold __________ Warrant Shares and hereby
represents that it has complied with the prospectus delivery requirements of the
Securities Act as applicable in connection with such sale.]3 

Date: __________________, ______

 

	Name of Registered
      Holder 	 

	By:	 	 
	 	Name: 	 
	 	Title: 	 

________________________________
            
3 Add only if a contemporaneous sale has occurred pursuant to a
Registration Statement 

27

EXHIBIT B 

SECOND TRANCHE WARRANT 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT
BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED EXCEPT IN ACCORDANCE
WITH THE PROVISIONS OF REGULATION S PROMULGATED UNDER THE SECURITIES ACT,
PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS INVOLVING THE SECURITIES
REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES
ACT. THIS CERTIFICATE MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT
AS A CONDITION PRECEDENT TO THE SALE, PLEDGE, HYPOTHECATION OR ANY OTHER
TRANSFER OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED BY THIS
CERTIFICATE. 

WHITE MOUNTAIN TITANIUM CORPORATION 

SECOND TRANCHE WARRANT
TO PURCHASE COMMON
STOCK 

Warrant No.: W-____ 
Number of Shares:
_________________
Date of Issuance: ___________________, 201____ (the
“Issuance Date”) 

             White
Mountain Titanium Corporation, a Nevada corporation (the “Company”),
hereby certifies that, for good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, ____________________, the
registered holder hereof or its permitted assigns (the “Holder”), is
entitled, subject to the terms set forth below, to purchase from the Company, at
the Exercise Price (as defined below) then in effect, upon surrender of this
Warrant to Purchase Common Stock (including all Warrants to Purchase Common
Stock issued in exchange, transfer or replacement hereof, the “Warrant”),
at any time or times on or after the date hereof, but not after 11:59 P.M., New
York Time, on the Expiration Date (as defined below),
_______________________(_________) fully paid nonassessable shares of Common
Stock (as defined below) (the “Warrant Shares”). Except as
otherwise defined herein, capitalized terms in this Warrant shall have the
meanings set forth in Section 12. This Warrant is one of the Second Tranche
Warrants issued pursuant to the Binding Memorandum of Understanding dated
November ___, 2013, between the Company and Grand Agriculture Investment
Limited. 

            
1.           EXERCISE
OF WARRANT. 

                             1.1        
Mechanics of Exercise. Subject to the terms and conditions
hereof, this Warrant may be exercised by the Holder on any day, in whole or in
part, by (i) delivery of a written notice, in the form attached hereto as
Exhibit A (the “Exercise Notice”), of the Holder’s election to
exercise this Warrant and (ii) payment to the Company of an amount equal to the
applicable Exercise Price multiplied by the number of Warrant Shares as to which
this Warrant is being exercised (the “Aggregate Exercise Price”) in cash
or wire transfer of immediately available funds. The Holder shall not be
required to deliver the original Warrant in order to effect an exercise
hereunder; provided, however, that the Holder shall covenant in the
Exercise Notice, that it will deliver the original Warrant to the Company within
five (5) Business Days of such exercise. Execution and delivery of the Exercise
Notice with respect to less than all of the Warrant Shares shall have the same
effect as cancellation of the original Warrant and issuance of a new Warrant
evidencing the right to purchase the remaining number of Warrant Shares. On or
before the first Business Day following the date on which the Company has
received each of the Exercise Notice and the Aggregate Exercise Price (the
“Exercise Delivery Documents”), the Company shall transmit by facsimile
an acknowledgment of confirmation of receipt of the Exercise Delivery Documents
to the Holder and the Company’s transfer agent (the “Transfer Agent”). On
or before the third Business Day following the date on which the Company has
received all of the Exercise Delivery Documents (the “Share Delivery
Date”), the Company shall (X) provided that the Transfer Agent is
participating in The Depository Trust Company (“DTC”) Fast Automated
Securities Transfer Program, upon the request of the Holder, credit such
aggregate number of shares of Common Stock to which the Holder is entitled
pursuant to such exercise to the Holder’s or its designee’s balance account with
DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the
Transfer Agent is not participating in the DTC Fast Automated Securities
Transfer Program, issue and dispatch by overnight courier to the address as
specified in the Exercise Notice, a certificate, registered in the name of the
Holder or its designee, for the number of shares of Common Stock to which the
Holder is entitled pursuant to such exercise. Upon delivery of the Exercise
Notice and Aggregate Exercise Price referred to in clause (ii)(A) above the
Holder shall be deemed for all corporate purposes to have become the holder of
record of the Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date of delivery of the certificates evidencing
such Warrant Shares. If this Warrant is submitted in connection with any
exercise pursuant to this Section 1(a) and the number of Warrant Shares
represented by this Warrant submitted for exercise is greater than the number of
Warrant Shares being acquired upon an exercise, then the Company shall as soon
as practicable and in no event later than three (3) Business Days after any
exercise and at its own expense, issue a new Warrant (in accordance with Section
5(d)) representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant, less the
number of Warrant Shares with respect to which this Warrant is exercised. No
fractional shares of Common Stock are to be issued upon the exercise of this
Warrant, but rather the number of shares of Common Stock to be issued shall be
rounded up to the nearest whole number. The Company shall pay any and all taxes,
including without limitation, all documentary stamp, transfer or similar taxes,
or other incidental expense that may be payable with respect to the issuance and
delivery of Warrant Shares upon exercise of this Warrant. 

                             1.2        
Exercise Price. For purposes of this Warrant, “Exercise Price”
means US$0.55 per share, subject to adjustment as provided herein. 

                             1.3        
Disputes. In the case of a dispute as to the determination of
the Exercise Price or the arithmetic calculation of the Warrant Shares, the
Company shall promptly issue to the Holder the number of Warrant Shares that are
not disputed and resolve such dispute in accordance with Section 10. 

                             1.4        
No Fractional Shares or Scrip. No fractional shares or scrip
representing fractional shares shall be issued upon the exercise of this
Warrant. In lieu of any fractional share to which the Holder would otherwise be
entitled, the Company shall make a cash payment equal to the fair market value
of such fractional share.

                            
1.5         
 Compliance with Securities Laws.

                             (a)        
The Holder of this Warrant, by acceptance hereof, acknowledges that this Warrant
and the Common Stock to be issued upon exercise hereof are being acquired solely
for the Holder’s own account and not as a nominee for any other party; and for
investment, and that the Holder will not offer, sell or otherwise dispose of this
Warrant or any Common Stock to be issued upon exercise hereof except under
circumstances that will not result in a violation of the Securities Act or any
state securities laws. Upon exercise of this Warrant, the Holder shall, if
requested by the Company, confirm in writing, in a form satisfactory to the
Company, that the Common Stock so purchased are being acquired solely for the
Holder’s own account and not as a nominee for any other party, for investment,
and not with a view toward distribution or resale.

29

                                     (b)        
This Warrant and all Common Stock issued upon exercise hereof unless registered
under the Securities Act shall be stamped or imprinted with a legend in
substantially the following form (in addition to any legend required by state
securities laws):

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR
HYPOTHECATED EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S
PROMULGATED UNDER THE SECURITIES ACT, PURSUANT TO REGISTRATION UNDER THE
SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING
TRANSACTIONS INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED
UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. THIS CERTIFICATE MUST BE
SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE
SALE, PLEDGE, HYPOTHECATION OR ANY OTHER TRANSFER OF ANY INTEREST IN ANY OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE. 

            
2.        
ORGANIC CHANGE.

                          Any
recapitalization, reorganization, reclassification, consolidation, merger, sale
of all or substantially all of the Company’s assets to another Person or other
transaction, in each case which is effected in such a way that holders of Common
Stock are entitled to receive securities or assets with respect to or in
exchange for Common Stock is referred to herein as an “Organic Change.”
Prior to the consummation of any (i) sale of all or substantially all of the
Company’s assets to an acquiring Person or (ii) other Organic Change following
which the Company is not a surviving entity, the Company will secure from the
Person purchasing such assets or the Person issuing the securities or providing
the assets in such Organic Change (in each case, the “Acquiring Entity”)
a written agreement to deliver to the Holder in exchange for this Warrant, a
security of the Acquiring Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant and reasonably satisfactory to the
holder of this Warrant (including an adjusted exercise price equal to the value
for the Common Stock reflected by the terms of such consolidation, merger or
sale, and exercisable for a corresponding number of shares of Common Stock
acquirable and receivable upon exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant), if the value so reflected is less
than the Exercise Price in effect immediately prior to such consolidation,
merger or sale). In the event that an Acquiring Entity is directly or indirectly
controlled by a company or entity whose common stock or similar equity interest
is listed, designated or quoted on a securities exchange or trading market, the
Holder may elect to treat such Person as the Acquiring Entity for purposes of
this Section 2. Notwithstanding the foregoing, at the Holder’s option and
request, the Acquiring Entity shall purchase the Warrant from such Holder for a
purchase price, payable in cash within five (5) Business Days after such request
(or, if later, on the effective date of the Organic Change), equal to the value
of the remaining unexercised portion of this Warrant on the date of such
request, which value shall be computed using the Black-Scholes option pricing
model with such assumptions and inputs as are reasonably satisfactory to the
Company. The terms of any agreement pursuant to which a Organic Change is
effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this Section
2 and insuring that the Warrants (or any such replacement security) will be
similarly adjusted upon any subsequent transaction analogous to an Organic
Change. Prior to the consummation of any other Organic Change, the Company shall
make appropriate provision to insure that the Holder thereafter will have the
right to acquire and receive in lieu of or in addition to (as the case may be)
the shares of Common Stock immediately theretofore acquirable and receivable
upon the exercise of this Warrant (without regard to any limitations on the
exercise of this Warrant), such shares of stock, securities or assets that would
have been issued or payable in such Organic Change with respect to or in
exchange for the number of shares of Common Stock which would have been
acquirable and receivable upon the exercise of this Warrant as of the date of
such Organic Change (without regard to any limitations on the exercise of this
Warrant).

30

                             If,
prior to the exercise of this Warrant, the Company shall have effected one or
more stock split-ups, stock dividends or other increases or reductions of the
number of shares of its Common Stock outstanding without receiving reasonable
compensation therefor in money, services, or property, the number of shares of
Common Stock subject to this Warrant shall, (i) if a net increase shall have
been effected in the number of outstanding shares of Common Stock, be
proportionately increased, and the cash consideration payable per share shall be
proportionately reduced, and, (ii) if a net reduction shall have been effected
in the number of outstanding shares of Common Stock, be proportionately reduced
and the cash consideration payable per share be proportionately increased.

            
3.        
NONCIRCUMVENTION. The Company hereby covenants and agrees that
the Company will not, by amendment of its Articles of Incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms of this Warrant, and
will at all times in good faith carry out all the provisions of this Warrant and
take all action as may be required to protect the rights of the Holder. 

            
4.       
   WARRANT HOLDER NOT DEEMED A STOCKHOLDER.
Except as otherwise specifically provided herein, the Holder, solely in such
Person’s capacity as a holder of this Warrant, shall not be entitled to vote or
receive dividends or be deemed the holder of shares of the Company for any
purpose, nor shall anything contained in this Warrant be construed to confer
upon the Holder, solely in such Person’s capacity as the Holder, any of the
rights of a shareholder of the Company or any right to vote, give or withhold
consent to any corporate action (whether any reorganization, issue of stock,
reclassification of stock, consolidation, merger, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or
otherwise, prior to the issuance to the Holder of the Warrant Shares which such
Person is then entitled to receive upon the due exercise of this Warrant. In
addition, nothing contained in this Warrant shall be construed as imposing any
liabilities on the Holder to purchase any securities (upon exercise of this
Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company.
Notwithstanding this Section 4, the Company will provide the Holder with copies
of the same notices and other information given to the stockholders of the
Company generally, contemporaneously with the giving thereof to the
stockholders. 

            
5.  
        REISSUANCE OF
WARRANTS. 

                             5.1        
Transfer of Warrant. If this Warrant is to be transferred, the Holder
shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in
accordance with Section 5(d)), registered as the Holder may request,
representing the right to purchase the number of Warrant Shares being
transferred by the Holder and, if less then the total number of Warrant Shares
then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 5(d)) to the Holder
representing the right to purchase the number of Warrant Shares not being
transferred. 

31

                             5.2        
Lost, Stolen or Mutilated Warrant. Upon receipt by the Company
of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant, and, in the case of loss, theft or
destruction, of any indemnification undertaking by the Holder to the Company in
customary form and, in the case of mutilation, upon surrender and cancellation
of this Warrant, the Company shall execute and deliver to the Holder a new
Warrant (in accordance with Section 5(d)) representing the right to purchase the
Warrant Shares then underlying this Warrant. 

                             5.3        
Warrant Exchangeable for Multiple Warrants. This Warrant is
exchangeable, upon the surrender hereof by the Holder at the principal office of
the Company, for a new Warrant or Warrants (in accordance with Section 5(d))
representing in the aggregate the right to purchase the number of Warrant Shares
then underlying this Warrant, and each such new Warrant will represent the right
to purchase such portion of such Warrant Shares as is designated by the Holder
at the time of such surrender; provided, however, that no Warrants for
fractional shares of Common Stock shall be given. 

                             5.4        
Issuance of New Warrants. Whenever the Company is required to issue a new
Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of
like tenor with this Warrant, (ii) shall represent, as indicated on the face of
such new Warrant, the right to purchase the Warrant Shares then underlying this
Warrant (or in the case of a new Warrant being issued pursuant to Section 5(a)
or Section 5(c), the Warrant Shares designated by the Holder which, when added
to the number of shares of Common Stock underlying the other new Warrants issued
in connection with such issuance, does not exceed the number of Warrant Shares
then underlying this Warrant), (iii) except for new warrants issued pursuant to
section 5(a), shall have an issuance date, as indicated on the face of such new
Warrant, which is the same as the Issuance Date, and (iv) shall have the same
rights and conditions as this Warrant. 

             6.         
 NOTICES. All notices, demands or other
communications to be given or delivered under or by reason of the provisions of
this Warrant shall be in writing and shall be deemed to have been given when
delivered personally to the recipient, sent to the recipient by facsimile
transmission, sent to the recipient by email, sent to the recipient by reputable
express courier service (charges prepaid), or three (3) Business Days after
being mailed to the recipient by certified or registered mail, return receipt
requested and postage prepaid. Such notices, demands, and other communications
will be sent to the Holder at the address or number indicated on the records of
the Company and to the principal executive offices of the Company, or to such
other address or to the attention of such other person as the recipient party
has specified by prior written notice to the sending party. 

             7.          
AMENDMENT AND WAIVER. Except as otherwise provided
herein, the provisions of this Warrant may be amended and the Company may take
any action herein prohibited, or omit to perform any act herein required to be
performed by it, only if the Company has obtained the written consent of the
holders of these Warrants representing at least a majority of the shares of
Common Stock obtainable upon exercise of these Warrants then outstanding;
provided, however, that the Company may reduce the Exercise Price or extend the
Expiration Date without the prior consent of the holders of these Warrants. 

             8.         
 GOVERNING LAW; VENUE; WAIVER OF JURY TRAIL. ALL
QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION
OF THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK. THE COMPANY AND THE WARRANT HOLDER
HEREBY IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE STATE
AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN FOR THE
ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR THE WARRANT HOLDER
HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR
DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE
TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN
ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR THE WARRANT HOLDER, ANY
CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT,
OR THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY
IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING
SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA
REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY)
TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS WARRANT AND
AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS
AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY
ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND THE
INVESTOR HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY. 

32

             9.         
 CONSTRUCTION; HEADINGS. This Warrant shall be
deemed to be jointly drafted by the Company and the Holder and shall not be
construed against any person as the drafter hereof. The headings of this Warrant
are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant. 

            
10.        
REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF.

The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant at law or in
equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit the right of the Holder to pursue actual
damages for any failure by the Company to comply with the terms of this Warrant.
The Company acknowledges that a breach by it of its obligations hereunder will
cause irreparable harm to the holder of this Warrant and that the remedy at law
for any such breach may be inadequate. The Company therefore agrees that, in the
event of any such breach or threatened breach, the Holder shall be entitled, in
addition to all other available remedies, to an injunction restraining any
breach, without the necessity of showing economic loss and without any bond or
other security being required. 

             11.        
TRANSFER. This Warrant may not be offered for sale, sold,
transferred or assigned without the consent of the Company.

             12.        
CERTAIN DEFINITIONS. For purposes of this Warrant, the following
terms shall have the following meanings: 

                             12.1        
“Business Day” means any day except Saturday, Sunday and any day
which is a federal or Canadian legal holiday or a day on which banking
institutions in the State of New York or the Province of British Columbia are
authorized or required by law or other governmental action to close. 

                             12.2        
“Common Stock” means (i) the Company’s common stock, par value
$0.001 per share, and (ii) any capital stock into which such Common Stock shall
have been changed or any capital stock resulting from a reclassification of such
Common Stock. 

33

                             12.3        
“Expiration Date” means December 31, 2017, or, if such
date falls on a day other than a Business Day or on which trading does not take
place on the Principal Market (a “Holiday”), the next date that is not a
Holiday.

                             12.4        
“Person” means an individual, a limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization, any
other entity and a government or any department or agency thereof. 

                             12.5        
“Principal Market” means the principal securities exchange or
trading market on which the Common Stock is listed and trades. 

34

             IN
WITNESS WHEREOF, the Company has caused this Warrant to Purchase Common
Stock to be duly executed as of the Issuance Date set out above. 

WHITE MOUNTAIN TITANIUM CORPORATION

 

	 	BY:	 
	 	 	Name: 
	 	 	Title: 

EXHIBIT A 

EXERCISE NOTICE 

TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT TO PURCHASE COMMON STOCK 

WHITE MOUNTAIN TITANIUM CORPORATION 

             The
undersigned holder hereby exercises the right to purchase ___________ of the
shares of Common Stock (“Warrant Shares”) of White Mountain Titanium
Corporation, a Nevada corporation (the “Company”), evidenced by the
attached Warrant to Purchase Common Stock (the “Warrant”). Capitalized
terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant. 

             1.
Payment of Exercise Price. The holder shall pay the Aggregate Exercise Price in
the sum of $___________________ to the Company in accordance with the terms of
the Warrant. 

             2.
Accredited Investor. The holder is an “accredited investor” as defined in Rule
501(c) under the Securities Act. 

             3.
Delivery of Warrant Shares. The Company shall deliver to the holder __________
Warrant Shares in accordance with the terms of the Warrant. 

             4.
Delivery of Warrant. The Holder shall deliver the original Warrant to the
Company within five (5) Business Days from the date hereof. 

             [5.
The Holder hereby represents that contemporaneous with the delivery of this
exercise notice, that the Holder has sold __________ Warrant Shares and hereby
represents that it has complied with the prospectus delivery requirements of the
Securities Act as applicable in connection with such sale.]4 

Date: __________________, ______

 

	Name of Registered
      Holder 	 

	By:	 	 
	 	Name: 	 
	 	Title: 	 

______________________________________________
            
4 Add only if a contemporaneous sale has occurred pursuant to a
Registration Statement 

36

EXHIBIT C 

REPRESENTATION FORM 

            
This Representation Form is furnished by the undersigned (the “Investor”)
in connection with the Binding Memorandum of Understanding dated November ___,
2013 (the “MOU”), between White Mountain Titanium Corporation, a Nevada
corporation (the “Company”), and Grand Agriculture Investment Limited, a
company formed in Hong Kong, and the sale of First and/or Second Tranche Units
as provided therein and consisting of the First and Second Tranche Shares and
Warrants and Warrant Shares (collectively the “Securities”) in a
non-public offering of the Securities (the “Offering”). The Investor has
agreed to purchase _____________________ [First Tranche/Second Tranche] Units
for gross proceeds of US$__________________, which funds have been tendered to
the Company. This transaction is intended to comply with Section 4(a)(2), and/or
Section 4(a)(5) of the Securities Act of 1933, as amended (the “Securities
Act”), Rule 506 of Regulation D promulgated by the Securities and Exchange
Commission (the “SEC”) under the Securities Act, and/or Regulation S
promulgated by the SEC under the Securities Act. Capitalized terms in this
Representation Form not otherwise defined shall have the same meaning as in the
MOU. In connection with the Offering, the undersigned represents and warrants to
the Company as set forth below. 

             12.1
Restricted Securities. The Investor has been advised and
acknowledges that: (i) neither the First or Second Tranche Units nor the Warrant
Shares have been, and when issued, will not be, registered under the Securities
Act, the securities laws of any state of the United States or the securities
laws of any other country or jurisdiction; (ii) it is a condition to the
availability of the Regulation S “safe harbor” that the Units not be offered or
sold in the United States or to a U.S. Person until the expiration of a period
of six months following the Second Closing Date (the “Restricted
Period”); and (iii) notwithstanding the foregoing, prior to the expiration
of Restricted Period, the Securities may be offered and sold by the Investor
only if such offer and sale is made in compliance with the terms of the MOU and
either: (i) if the offer or sale is within the United States or to or for the
account of a U.S. Person, the Securities are offered and sold pursuant to an
effective registration statement or pursuant to Rule 144 under the Securities
Act or pursuant to an exemption from the registration requirements of the
Securities Act; or (ii) the offer and sale is outside the United States and to
other than a U.S. Person. 

             12.2
Investment Intent. The Investor is acquiring the First and
Second Tranche Units for his, her or its own account for investment purposes
only and not with a view to or for distributing or reselling the securities. The
Investor does not have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the First or Second Tranche Units or the
Warrant Shares. 

             12.3
Investor Status. At the time the Investor was offered the
First and Second Tranche Units, he, she or it was, and at the date hereof it is,
an “accredited investor” as defined in Rule 501(a) under the Securities Act.

             12.4
Information. The Investor has been furnished (i) with all
requested materials relating to the business, finances, and operations of the
Company; (ii) with information deemed material to making an informed investment
decision; and (iii) with additional requested information necessary to verify
the accuracy of any documents furnished to it by the Company. The Investor have
been afforded the opportunity to ask questions of the Company and its management
and to receive answers concerning the terms and conditions of the Offering.

             12.5
Documents. The Investor have had access on the Commission
website (www.sec.gov) to the SEC Reports, including the exhibits thereto.
The Investor has relied upon the information contained therein and has not been
furnished any other material documents, literature, memorandum, or prospectus.

             12.6
Knowledge and Experience in Business and Financial Matters.
The Investor, or if the Investor is an entity, the persons representing the
Investor, has such knowledge and experience in business and financial matters
that he or she is capable of evaluating the risks of the prospective investment.
The financial capacity of the Investor is of such proportion that the total cost
of his, her or its commitment in the First and Second Tranche Units would not be
material when compared with his, her or its total financial capacity. 

             12.7
No Directed Selling Efforts. The Investor has not engaged, nor
is he, she or it aware that any party has engaged, and the Investor will not
engage or cause any third party to engage, in any directed selling efforts5
(as such term is defined in Regulation S) in the United States with
respect to the First or Second Tranche Units or the Warrant Shares. 

             12.8
Non-U.S. Person Status. The Investor: (i) is domiciled and has
its principal place of business outside the United States; (ii) is not a U.S.
Person and is not acquiring the First or Second Tranche Units or the Warrant
Shares for the account or benefit of any U.S. Person; and (iii) at the time of
the purchase of the Securities, the Investor or persons acting on his, her or
its behalf in connection therewith will be located outside the United States.

             12.9
Not a Distributor. The Investor is not a
distributor6 (as defined in Regulation S) or a dealer (as defined in
the Securities Act). 

             12.10
Transfer Limitations. The Investor acknowledges that the
Company shall make a notation in its stock books regarding the restrictions on
transfer set forth in the MOU and shall transfer the Unit Shares, the Warrants
and the Warrant Shares on the books of the Company only to the extent consistent
therewith. In particular, the Investor acknowledges that the Company shall
refuse to register any transfer of the Unit Shares, the Warrants or the Warrant
Shares not made in accordance with the provisions of Regulation S, pursuant to
registration under the Securities Act or pursuant to an available exemption from
registration. 

       
     12.11 Restrictive
Legend. The Investor understands and agrees that each certificate held
by it representing the Unit Shares, the Warrants and the Warrant Shares or any
other securities issued in respect of the First and Second Tranche Units or
Warrants shall bear substantially the following legend: 

THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, EXERCISED,
PLEDGED OR HYPOTHECATED EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S
PROMULGATED UNDER THE SECURITIES ACT, PURSUANT TO 

________________________________________________
5
In general, “directed selling efforts” means any activity undertaken for
the purpose, or that could reasonably be expected to have the effect, of
conditioning the market in the United States for the securities of the issuer.
Such activity includes placing an advertisement in a publication “with a general
circulation in the United States” that refers to the offering of the securities
being made in reliance upon this Regulation S. 
6 “Distributor”
means any underwriter, dealer, or other person who participates, pursuant to a
contractual arrangement, in the distribution of the securities. 

38

REGISTRATION UNDER THE SECURITIES ACT
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS
INVOLVING THE SECURITIES REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN
COMPLIANCE WITH THE SECURITIES ACT. THIS CERTIFICATE MUST BE SURRENDERED TO THE
COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, PLEDGE,
HYPOTHECATION OR ANY OTHER TRANSFER OF ANY INTEREST IN ANY OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE. 

             12.12
Compliance with Local Jurisdiction Laws. The Investor has
satisfied as to the full observance of the laws of his, her or its jurisdiction
in connection with this transaction, including: (i) the legal requirements
within its jurisdiction for the purchase of the First and Second Tranche Units
or the Warrant Shares, (ii) any foreign exchange restrictions applicable to such
purchases, (iii) any governmental or other consents that may need to be obtained
and (iv) the income tax and other tax consequences, if any, that may be relevant
to the purchase, holding, redemption, sale or transfer of such securities. The
Investor’s subscription and payment for, and its continued beneficial ownership
of, these securities will not violate any applicable securities or other laws of
his, her or its jurisdiction. 

             12.13
Compliance with MOU. The Investor agrees to abide by and be
bound by all applicable terms and conditions of the MOU, a copy of which is
attached hereto and incorporated herein. 

             IN
WITNESS WHEREOF, the undersigned has executed this Representation Form this ____
day of ___________________ 201____. 

             If
the undersigned is an INDIVIDUAL, complete the following: 

 

	Print Name of
      Individual 	 	Signature
      of Individual 

             If
the undersigned is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY, TRUST,
or other entity, complete the following: 

             NOTE:
By signing below, the individual executing this Representation Form on behalf of
the undersigned entity represents and warrants to the Company that (i) the
entity is duly authorized to enter into this Representation Form; (ii) he or she
is duly authorized to represent the entity in this transaction involving the
issuance of the Securities; and (iii) he or she is duly authorized to execute
this Representation Form on behalf of the entity. 

	
      Type or print the exact name of the Partnership,
      Corporation, Limited Liability Company, Trust, or other entity
  

39

	Type or print name of
      the individual 	 	Signature
      of the individual signing 
	signing on behalf of the partnership, 	 	on behalf of the partnership, corporation,
  
	corporation, limited liability 	 	limited liability company, trust or other

	company, trust or other entity 	 	entity 

40

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]